The venipunctures for biochemical examination were performed in the selected time intervals during the whole experiment (before and 24 hrs after the 1 st , 5 th , 8 th , and 10 th administration).
The concentration of cTnT in heparinized plasma samples was measured using Elecsys Troponin T STAT Immunoassay (Roche) on the Elecsys 2010 immunoassay analyser (Roche). The concentration of cTnI in heparinized plasma samples was measured using AxSYM Troponin I (Abbott) on the analyser AxSYM (Abbott).
Statistical analyses
Statistical evaluation was performed with the SigmaStat software program (revision STAT 32 2.0, Jandel GmbH, Erkrath, Germany).
Results
In the both control and Cremophor groups, the values of cTnT were very low (i.e. < 0.03 ng/ml). The repeated i.p. administration of SIH caused no statistically significant increase of cTnT levels in comparison either with the initial values or with both the control and the Cremophor groups. This observation confirmed very low cardiotoxicity of SIH declared in previous studies. The data about cTnT and cTnI are summarized in Table 1 and 2. Furthermore, we have studied relationship between cTnT (independent variable x) and cTnI (dependent variable Y) using linear regression in the form Y = α + βx + ε. First, we have tested the hypothesis that β = 0 which would mean that Y is independent of x. We have found out that hypothesis of independence was accepted only in the group following repeated administration of SIH and Cremophor but not in the control group. Further, the strength of dependence was measured with the coefficient of determination R 2 . R 2 was too small in all cases. The highest value of R 2 was found in the control group (R 2 = 0.424). It means that such a model is not suitable for prediction. The data are shown in the following figures; statistical characteristics are given in Table 3 .
Group
n before 1 st after 1 st before 5 th after 5 th before 8 th after 8 th before 10 th after 10 th administration administration administration administration administration administration administration administration Control 10 0.003 ± 0.003 0.014 ± 0.008 0.000 ± 0.000 0.005 ± 0.003 0.000 ± 0.000 0.008 ± 0.004 0.000 ± 0.000 0.013 ± 0.005 SIH 8 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 0.031 ± 0.018 0.000 ± 0.000 0.030 ± 0.011 0.004 ± 0.004 0.036 ± 0.022 Cremophor 5 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 0.010 ± 0.007 0.000 ± 0.000 0.015 ± 0.008
n before 1 st after 1 st before 5 th after 5 th before 8 th after 8 th before 10 th after 10 th administration administration administration administration administration administration administration administration Control 10 0.578 ± 0.271 2.670 ± 1.550 0.270 ± 0.127 0.170 ± 0.132 0.510 ± 0.285 0.512 ± 0.324 0.356 ± 0.203 0.510 ± 0.269 SIH 8 0.025 ± 0.025 0.088 ± 0.058 0.086 ± 0.071 0.000 ± 0.000 2.829 ± 2.829 0.287 ± 0.181 0.038 ± 0.038 0.000 ± 0.000 Cremophor 5 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 0.060 ± 0.060 0.275 ± 0.160 0.325 ± 0.325 0.000 ± 0.000 Tab. 1: Cardiac troponin T (cTnT) levels (ng/ml) following SIH.
Tab. 2:
Cardiac troponin I (cTnI) levels (ng/ml) following SIH.
Tab. 3:
Simple linear regression of cTnI depending on cTnT. 
Discussion
Troponin consisting of three subunits (TnT, TnC and TnI) belongs to the regulatory proteins involved in the regulation of muscle contraction in response to alterations in intracellular Ca 2+ concentrations. Both subunits, i.e. cTnT and cTnI, are considered to be reliable biomarkers with sufficient sensitivity and specificity for cardiac injury in the majority of laboratory animals (10,11). In our previous study (4) we measured serum concentration of both cardiomarkers in more than 100 samples obtained from rabbits under various conditions. A surprisingly strong dependence of cTnI on cTnT was found only in the control group. The group with repeated administration of daunorubicin and the second one with daunorubicin combined with dexrazoxane had the coefficients of determination too small to be considered acceptable. Similar results (i.e. no correlation between cTnT and cTnI) have been also reached in this study. Very low cTnT levels (i.e. < 0.03 ng/ml) following repeated administration of SIH almost exclude possible cardiotoxic effect of SIH and are in an agreement with other followed-up parameters (12) . On the other hand, the cTnI are widely scattered in all groups including the control group.
Better results with cTnT may be caused (except a little different characteristics, i.e. molecular weight, intracellular compartmentation etc.) by heterogenous nature and biochemical complexity of the serum forms of TnI and by differences of the epitope recognition using the various serum cTnI assays (5). Up to 20-fold variation of serum cTnI mass determinations may be observed for a given sample when measured by different assay systems (8) .
While only one commercial assay currently exists for cTnT determination using the monoclonal antibodies (Mab 7 and 7-11) against the central portion of the molecule, that is relatively stable and unaffected by the binding of TnT with other subunits, a number of cTnI assays are available recognizing different epitopes on the N-and C-termini of cardiac TnI. Four commonly used troponin I assays (Dade Behring Stratus, Beckman Coulter Access, Abbott AxSYM, and Dade Behring Opus) recognize the intact cardiac troponin molecule, the Stratus, Opus, and AxSYM assays recognize the N-terminal portion of the molecule, and the Access assay recognizes the C-terminal portion of the molecule (8) . Terminal portions of cTnI very often undergo oxidation and phosphorylation which can affect conformation of the molecule. Additionally, peripheral parts of cTnI are highly susceptible to proteolysis, and are often complexed with other troponin subunits that can also change the immunoreactivity of cTnI (5). While Katrukha et al. (6) reported that serum troponin I exists largely as a TnI-TnC binary complex with a small amount of free TnI present, Morjana (9) described that serum TnI exists predominantly as a ternary TnI-TnC-TnT complex. The extent of degradation may be related to the degree of myocardial damage.
To sum up, no meaningful dependence of cTnI on cTnT (with the exception of control group) has been found in rabbits. Although the choice of the best biochemical marker of myocardial damage does not seem to be simple and may differ from one species to another, further studies are needed because there is an increasing interest in the specific detection of myocardial damage in pre-clinical experiments (14) . According to our long-term experiences cTnT seems to be more suitable cardiomarker in rabbits in comparison with cTnI. 
